Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection
about
Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteinsInfluenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infectionCharacterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodiesAn oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infectionImmunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection.Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies.Recent advances in Brucella abortus vaccinesBrucellosis: the case for live, attenuated vaccines.Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice.Meta-Analysis and Advancement of Brucellosis Vaccinology.Immunization with individual proteins of the Lrp/AsnC family induces protection against Brucella melitensis 16M challenges in miceProtective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice.Progress in Brucella vaccine development.Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challengeCD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis.U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in MiceConfronting the barriers to develop novel vaccines against brucellosis.Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.Development and trial of vaccines against Brucella.Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.Activation of NF-kB-Mediated TNF-Induced Antimicrobial Immunity Is Required for the Efficient Brucella abortus Clearance in RAW 264.7 Cells.Alternative strategies for vaccination to brucellosis.Diagnostic potential of Brucella melitensis Rev1 native Omp28 precursor in human brucellosis.Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection.
P2860
Q27311087-148F6712-8FD7-4D8B-8359-423739576A70Q28658422-6262B55F-53A2-4CC6-8EC8-ACE54FDF4ED2Q33691610-013C7530-564D-4568-8A26-5E8AB51CA74BQ33802696-5373014C-CC5E-49E4-B4A4-E9CB5EA4B372Q33848963-ED060C1D-6C1C-493A-8460-B5E6E5E7690FQ34181433-033B9A6E-E281-406A-9CB8-5CEF2C62644BQ34212243-DFEC9FC8-D0B8-425A-BE01-242F6634B9EEQ34484123-C987546C-E3B0-43B8-976E-AAD6E2521789Q34612868-D1F5D4D3-FE57-441D-BCDF-FDB11DAF69E0Q35191851-9503A22D-F6DF-4DEE-BE19-051FE693E019Q35661526-7E38FAB6-91BB-4C43-A4D2-AB942C18CB9FQ36192841-50675B8A-9225-44AD-9C2C-04B938495539Q36222924-2F496BD2-E9D5-4CC5-998C-CE93D22F3CB4Q36306609-114AFDDD-0CEC-4CFC-9545-932ADDC57184Q36883753-CEEF5E56-94B0-4D2D-9F40-F00F60B1C476Q36932453-E248DAED-9189-49AC-83D0-B482CC117E25Q37316341-66A6D6F5-2A70-4FA0-872C-F64796B465CFQ37647549-6B1FD14D-2ACD-41EF-85E2-5717AE9305B9Q37932521-8FBC26F7-9F90-4240-9DD1-B8D8B7C26DD5Q37965725-C511F6A9-CAE5-490C-B0C5-4C9F3A364270Q38110546-473983B2-F164-4E1E-A2EC-D05F24138F32Q40072449-20033716-8DD6-4AC0-9E78-04279B207E78Q41459448-47129230-FCAE-4791-84C0-153CDFFA383CQ42283292-78358D50-B8EE-48C5-98AD-99892765404EQ43177186-C7EACF45-52FF-4D34-B7E1-34CE7A27A6F1Q46258488-9E03B8CD-F55C-4FC5-BA7E-48B5D6EE79BFQ46276535-4A2AFF7B-6094-4DA6-9880-C03BE3DF67E2Q49486807-FA056EBE-E753-41B3-93F1-A6642E15D5E2Q55112400-F8F65C60-75CD-4C5E-929A-AD22B030A213Q55226818-BD235101-186A-4A69-AD73-4A6CC9063609
P2860
Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Immunization with recombinant ...... nst Brucella abortus infection
@en
Immunization with recombinant ...... st Brucella abortus infection.
@nl
type
label
Immunization with recombinant ...... nst Brucella abortus infection
@en
Immunization with recombinant ...... st Brucella abortus infection.
@nl
prefLabel
Immunization with recombinant ...... nst Brucella abortus infection
@en
Immunization with recombinant ...... st Brucella abortus infection.
@nl
P2093
P2860
P50
P356
P1476
Immunization with recombinant ...... nst Brucella abortus infection
@en
P2093
Astrid Zwerdling
Clara García Samartino
Guillermo H Giambartolomei
Lorena M Coria
Paula Barrionuevo
Silvia M Estein
P2860
P304
P356
10.1128/IAI.01151-08
P407
P577
2008-11-03T00:00:00Z